"Roughly 22,000 GIC members currently take GLP-1 medications for weight loss, costing the state about $46 million, according to Margaret Anshutz, the agency's director of health policy and analytics, at the meeting. The pressure of rising drug spending prompted the governor to ask the commission to find about $100 million in savings."
"As the largest purchaser of health insurance in Massachusetts, we're a crucial part of the effort. If we cut coverage collectively, we have market power to push those prices down to get access for our membership. Eliminating the benefit is expected to bring premium growth down to an average of 7.5%, the smallest increase in years."
"Commissioners who opposed the move warned it could deepen health disparities and potentially raise costs later if members with chronic conditions worsen."
The Massachusetts Group Insurance Commission voted to eliminate GLP-1 drug coverage for weight loss among state employees, affecting approximately 22,000 current users. The decision, driven by $46 million in annual costs and pressure to find $100 million in budget savings, passed narrowly 10-7. Governor Maura Healey encouraged the commission to pursue this specific measure rather than broader cost-cutting options like higher co-pays and deductibles. Officials argue the move leverages Massachusetts's position as the largest health insurance purchaser to negotiate lower drug prices with manufacturers. Opponents warned the decision could worsen health disparities and increase future costs if members develop chronic conditions. The elimination is projected to reduce premium growth to 7.5%, the smallest increase in years.
#glp-1-drug-coverage #state-employee-health-insurance #budget-constraints #pharmaceutical-pricing #health-equity
Read at Boston.com
Unable to calculate read time
Collection
[
|
...
]